July 30, 2009 — (Bronx, NY) — Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University today announced a new ten-year agreement to continue their existing partnership and strengthen their ties in clinical care, medical research and teaching.  The two nationally known medical institutions have been affiliated since 1963 and are committed to expanding their well-established and highly successful relationship.

Allen M. Spiegel, M.D., Einstein's Marilyn and Stanley M.
Katz Dean (left), and Steven M. Safyer, M.D., President
and CEO of Montefiore Medical Center, today announced
a new ten-year agreement to continue their existing
partnership and strengthen ties in clinical care, medical
research and teaching."This agreement, while clearly recognizing the ongoing independence of both organizations, provides a long-term framework that will streamline collaborations in clinical, research and teaching programs," said Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean of Albert Einstein College of Medicine.

"The agreement is forward looking and fortifies each of our missions and core programs," said Steven M. Safyer, M.D., president and CEO of Montefiore. "It enhances our ability to recruit the best and brightest faculty and clinical staff in the nation; to spearhead new clinical trials in areas such as heart disease, cancer, pediatrics, transplant, and neurosciences; to create a model teaching environment for the 21st century; and to advance the health of the communities we serve."

The new long-term agreement demonstrates a renewed level of commitment that will align key strategic directions and raise the stature of both organizations by:

• Centering the administration of most new clinical and translational research sponsored by the National Institutes of Health at Einstein;
• Assuring the role of Montefiore as the primary clinical training site for Einstein programs;
• Increasing the representation of each institution on the other party's governing board;
• Providing a framework for identifying and cultivating joint opportunities for philanthropic development; and
• Identifying approaches to co-brand select clinical programs.